News
)
27 October 2023
VIVEbiotech at the Feria de Empleo PICE 2023
VIVEbiotech will participate in the Feria de Empleo PICE 2023 that will take place at the headquarters of the Chamber of Gipuzkoa, next Tuesday, October 31 from 9:30...
Read more)
26 October 2023
VIVEbiotech is participating in the ESGCT Annual Congress taking place in Brussels this week
VIVEbiotech is participating in the ESGCT (European Society of Gene and Cell Therapy) Annual Congress taking place in Brussels this week.
Read more)
24 October 2023
VIVEbiotech received last night the “Business Innovation” award at the XXXII edition of the Basque Business Night
VIVEbiotech received last night the "Innovacion Empresarial/Business Innovation" award at the XXXII edition of the La Noche de la Empresa Vasca/Basque Business Night...
Read more)
12 October 2023
VIVEbiotech is participating in Innovative Therapies Days
VIVEbiotech is participating in Innovative Therapies Days, "an oasis of innovation 2.5 hours from Paris"!
Read more)
11 October 2023
VIVEbiotech participates one more year in the Cell & Gene Meeting on the Mesa
VIVEbiotech is participating once again in the Cell & Gene Meeting on the Mesa congress in California.
Read more)
9 October 2023
VIVEbiotech featured in an article in BioPharm International
VIVEbiotech has been featured in an article in BioPharm International
Read more)
28 September 2023
VIVEbiotech: A Lentiviral Vector Specialist Bridging the Gap Between R&D and Commercialisation
An article featured by Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, has just been published by European Pharmaceutical Manufacturer.
Read more)
14 September 2023
The Medicine Maker publishes an opinion article after interviewing Natalia Elizalde
The Medicine Maker has published an opinion article after interviewing Natalia Elizalde, VIVEbiotech´s Chief Business Development Officer.
Read more)
24 August 2023
VIVEbiotech will lead a session with speakers from top international companies during upcoming Biospain
Biospain is a biotechnology congress organized by AseBio - Asociación Española de Empresas Biotecnológicas and is held every two years in a...
Read more)
14 August 2023
Contribution to an article defining the benefits of lentiviruses in BioPharm International
In a recent article in BioPharm International, Chris Spivey speaks about different types of viral vectors that are regularly used in gene therapy, each with...
Read moreDestacadas
)
)
)
)
){kind=spacer}
4 March 2024
Spanish researchers to design proteins using AI to make advanced therapies more efficient
)
)
14 February 2024
VIVEbiotech forecasts significant growth in lentiviral vectors and CAR-T therapies for 2024
)
)
9 February 2024
)